Pre-Recorded

Plenary Presentation

Lung Cancer

The majority of patients with lung cancer are diagnosed after 65 years of age, and while several treatment options exist for older patients, they can be associated with significant morbidity, mortality, and adverse effects on quality of life - due in part to frailty. Frailty is a syndrome of physiological decline in later life, characterized by significant vulnerability to adverse health outcomes including procedural complications, falls, disability, and death. Decision making regarding screening and treatment in older patients is difficult due to their underrepresentation in clinical trials and a lack of evidence on risk stratification for patients can be considered frail.

Review and critique existing frailty scoring instruments and determine which are most appropriate in the evaluation of elderly patients with lung cancer.

Describe effects of frailty on the diagnosis and medical treatment of lung cancer.